Optogenetic gene therapy holds great promise for healing blindness. Hulliger et al have developed a new promoter that effectively targets human ON bipolar cells. This is an important step towards clinical applications of optogenetic gene therapy for restoring vision.
Expert to Expert Interview with Dr. Jeff Jamison (Experimentica Ltd)
Watch the interview with our new collaboration partner Dr. Jeff Jamison, Director of In Vivo Pharmacology at Experimentica Ltd, and developer of AcuiSee.